PKB/AKT: Functional insights from genetic models

Nature Reviews Molecular Cell Biology

Volumn 2, Issue 10, 2001, Pages 760-768

  Scheid, Michael P ^a   Woodgett, James R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AKT1 PROTEIN, DROSOPHILA; AKT1 PROTEIN, HUMAN; DROSOPHILA PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DROSOPHILA; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; DROSOPHILA; DROSOPHILA PROTEINS; ENZYME ACTIVATION; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 0035489468     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35096067     Document Type: Review

References (94)

1. Franke, T. F. et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinostol 3-kinase. Cell 81, 727-736 (1995).
2. Franke, T. F., Kaplan, D. R., Cantley, L. C. & Toker, A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665-668 (1997).
3. Bellacosa, A., Testa, J. R., Staal, S. P. & Tsichlis, P. N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254, 274-277 (1991).
4. Okano, J., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K. & Nakagawa, H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275, 30934-30942 (2000).
5. Alessi, D. R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551 (1996). Identification of the phosphorylation mechanism of PKB/AKT activation (at Thr308 and Ser473), initiating the hunt for upstream kinases.
6. Andjelkovic, M. et al. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515-31524 (1997).
7. Alessi D. R. et al. 3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776-789 (1997).
8. Alessi D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr. Biol. 7, 261-269 (1997) Purification and identification of PDK-1, the T-loop kinase responsible for activating PKB/AKT. Also see reference 9.
9. Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710-714 (1998).
10. Schubert, K. M., Scheid, M. P. & Duronio, V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275, 13330-13335 (2000).
11. Brodbeck, D., Hill, M. M. & Hemmings, B. A. Two splice variants of protein kinase B gamma have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site serine 472 in the carboxyl-terminal hydrophobic domain. J. Biol. Chem. 276, 29550-29558 (2001).
12. Toker, A. & Newton, A. C. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem. 275, 8271-8274 (2000).
13. Newton, A. C. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9, 161-167 (1997).
14. Williams, M. R. et al. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448 (2000).
15. Hill, M. M. et al. Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J. Biol. Chem. 276, 25643-25646 (2001).
16. Vanhaesebroeck, B. & Alessi, D. R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576 (2000).
17. Delcommenne, M. et al. Phosphoinositide-3-OH kinase-dependent regulation of GSK-3 and PKB/AKT by the integrin linked kinase (ILK). Proc. Natl Acad. Sci. USA 95, 11211-11216 (1998).
18. Persad, S. et al. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 276, 27462-27469 (2001).
19. Lynch, D. K., Ellis, C. A., Edwards, P. A. & Miles, I. D. Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene 18, 8024-8032 (2000).
20. Belham, C., Comb, M. J. & Avruch, J. Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr. Biol. 11, 1155-1167 (2001).
21. Chan, T. O., Rittenhouse, S. E. & Tsichlis, P. N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68, 965-1014 (1999).
22. Obata, T. et al. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J. Biol. Chem. 275, 36108-36115 (2000).
23. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995). One of the first physiological substrates identified for PKB/AKT.
24. Deprez, J., Vertommen, D., Alessi, D. R., Hue, L. & Rider, M. H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J. Biol. Chem. 272, 17269-17275 (1997).
25. Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231-241 (1997).
26. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999).
27. Biggs III, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K. & Arden, K. C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl Acad. Sci. USA 96, 7421-7426 (1999).
28. Kops, G. J. et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 398, 630-634 (1999).
29. Medema, R. H., Kops, G. J., Bos, J. L. & Burgering, B. M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 13, 782-787 (2000).
30. Diehl, J. A., Cheng, M., Roussel, M. F. & Sherr, C. J. Glycogen synthase kinase-3 beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511 (1998).
31. Rossig, L. et al. Akt-dependent phosphorylation of p21 (Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell Biol. 21, 5644-5657 (2001).
32. Zimmermann, S. & Moelling, K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744 (1999).
33. Rommel, C. et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741 (1999).
34. Guan, K. L. et al. Negative regulation of the serine/threonine kinase B-Raf by Akt. J. Biol. Chem. 275, 27354-27359 (2000).
35. Michell, B. J. et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 9, 845-848 (1999).
36. Dimmeler, S. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605 (1999).
37. Fulton, D. et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601 (1999).
38. Scott, P. H., Brunn, G. J., Kohn, A. D., Roth, R. A. & Lawrence, J. C. Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signalling pathway. Proc. Natl Acad. Sci. USA 95, 7772-7777 (1999).
39. Nave, B. T., Ouwens, M., Withers, D. J., Alessi, D. R. & Shepherd, P. R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427-431 (1999).
40. Altiok, S.et al. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-kinase/AKT in breast cancer cells. J. Biol. Chem. 274, 32274-32278 (1999).
41. Ozes, O. N. et al. NF-kappa-B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85 (1998).
42. Romashkova, J. A. & Makarov, S. S. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90 (1999).
43. Yaffe, M. B. et al. A motif-based profile scanning approach for genome-wide prediction of signalling pathways. Nature Biotechnol. 19, 348-353 (2001).
44. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728-1731 (2001). First PKB/Akt knockout paper, demonstrating the unexpected finding of a specific role for PKBβ/Akt2 in glucose homeostasis.
45. Chen, W. S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev. 15, 2203-2208 (2001).
46. Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R. & Muller, W. J. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol. 21, 2203-2212 (2001).
47. Siegel, P. M., Hardy, W. R. & Muller, W. J. Mammary gland neoplasia: insights from transgenic mouse models. Bioessays 22, 554-563 (2000).
48. Holland, E. C. et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genet. 25, 55-57 (2000).
49. Rodriguez-Viciana, P. et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532 (1994).
50. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998). First biological demonstration that PTEN negatively regulates PKB/AKT.
51. Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169-1178 (1998).
52. Jones, R. G. et al. Protein kinase B regulates T lymphocyte survival, nuclear factor KB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191, 1721-1734 (2000).
53. Parsons, M. J. et al. Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. J. Immunol. 167, 42-48 (2001).
54. -/- mice. Science 285, 2122-2125 (1999).
55. Kobayashi, T. & Cohen, P. Activation of serum-and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem. J. 339, 319-328 (1999).
56. Park, J. et al. Serum and glucocorticoid-inducible kinase (SGK) is a target of the Pl 3-kinase-stimulated signalling pathway. EMBO J. 18, 3024-3033 (1999). This report provided the first evidence that SGK is downstream of Pl3K.
57. Casamayor, A., Torrance, P. D., Kobayashi, T., Thorner, J. & Alessi, D. R. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast. Curr. Biol. 9, 186-197 (1999).
58. Sun, Y. et al. Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. Mol. Cell. Biol. 20, 4411-4419 (2000).
59. Brunet, A. et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952-965 (2001). This paper provided evidence that SGK targets similar substrates to PKB/AKT.
60. Zhang, B. H. et al. Serum and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. J. Biol. Chem. 276, 31620-31626 (2001).
61. Balendran, A. et al. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol. 9, 393-404 (1999).
62. Biondi, R. M., Kieloch, A., Currie, R. A., Deak, M. & Alessi, D. R. The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J. 20, 4380-4390 (2001).
63. Balendran, A, Currie, R., Armstrong, C. G., Avruch, J. & Alessi, D. R. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252. J. Biol. Chem. 274, 37400-37406 (1999).
64. Liu, D., Yang, X. & Songyang, Z. Identificatran of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr. Biol. 10, 1233-1236 (2000).
65. Ellson, C. D. et al. Ptdlns(3)P regulates the neutrophil oxidase complex by binding to the PX domain of p40phox. Nature Cell Biol. 3, 679-682 (2001).
66. Kanal, F. et al. The PXdomains of p47phox and p40phox bind to lipid products of Pl(3)K. Nature Cell Biol. 3, 675-678 (2001).
67. Cheever, M. L. et al. Phox domain interaction with Ptdlns(3)P targets the Vam7 t-SNARE to vacuole membranes. Nature Cell Biol. 3, 613-618 (2001).
68. Xu, J., Liu, D., Gill, G. & Songyang, Z. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides. J. Cell. Biol. 20, 699-706 (2001).
69. Virgilio, L. et al. Identification of the TCL1 gene involved in T-cell malignancies. Proc. Natl Acad. Sci. USA 91, 12530-12534 (1994).
70. Laine, J., Kunstle, G., Obata, T., Sha, M. & Noguchi, M. The protooncogene TCL1 is an Akt kinase coactivator. Mol. Cell. 6, 395-407 (2000).
71. Vanhaesebroeck, B. et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602 (2001).
72. Taylor, V. et al. 5′ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20, 6860-6871 (2000).
73. Krystal, G. Lipid phosphatases in the immune system. Semin. Immunol. 12, 397-403 (2000).
74. D'Cristofano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100, 387-390 (2000).
75. Shayesteh, L. et al. PlK3CA is implicated as an oncogene in ovarian cancer. Nature Genet. 21, 99-102 (1999).
76. Sun, M. et al. AKT1/PKB α kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159, 431-437 (2001).
77. Liu, W., James, C. D., Frederick, L., Alderete, B. E. & Jenkins, R. B. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57, 5254-5257 (1997).
78. Cairns, P. et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57, 4997-5000 (1997).
79. Risinger, J. I., Hayes, A. K., Berchuck, A. & Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57, 4736-4738 (1997).
80. Sun, H. et al. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am. J. Clin. Pathol. 115, 32-38 (2001).
81. Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64-67 (1997).
82. Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998). The paper that turned the tide in understanding PTEN's role.
83. Paradis, S. & Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488-2498 (1998). The first genetically identified PKB/AKT target, DAF-16, is a forkhead-like transcription factor - a prelude to the identification of mammalian homologues of PKB/AKT substrates.
84. Cho, K. S. et al. Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3 kinase-dependent signaling pathway. Proc. Natl Acad. Sci. USA 98, 6144-6149 (2001).
85. Wolkow, C. A., Kimura, K. D., Lee, M. S. & Ruvkun, G. Regulation of C. elegans life-span by insulin like signaling in the nervous system. Science 290, 147-150 (2000).
86. Pierce, S. B. et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev. 15, 672-686 (2001).
87. Paradis, S., Ailion, M., Token A., Thomas, J. H. & Ruvkun, G. A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev. 13, 1438-1452 (1999).
88. Scanga, S. E. et al.The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene 19, 3971-3977 (2000).
89. Staveley, B. E. et al. Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8, 599-602 (1998). Genetic evidence of a conserved role for PKB/AKT in suppressing apoptosis.
90. Verdu, J., Buratovich, M. A., Wilder, E. L. & Birnbaum, M. J. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nature Cell Biol. 1, 500-506 (1999).
91. Zhou, K., Takegawa, K., Emr, S. D. & Firtel, R. A. A phosphatidylinositol (Pl) kinase gene family in Dictyostelium discoideum: biological roles of putative mammalian p110 and yeast Vps34p Pl3-kinase homologs during growth and development. Mol. Cell. Biol. 15, 5645-5656 (1995).
92. Lim, C. J., Spiegelman, G. B. & Weeks, G. RasC is required for optimal activation of adenylyl cyclase and Akt/PKB during aggregation. EMBO J. 20, 4490-4499 (2001).
93. Meili, R. et al. Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J. 18, 2092-2105 (1999).
94. Chung, C. Y., Potikyan, G. & Firtel, R. A. Control of cell polarity and chemotaxis by Akt/PKB and Pl3 kinase through the regulation of PAKa. Mol. Cell 7, 937-947 (2001).